Key Players
Competitive Landscape
Large beauty groups compete for the shopper's daily routine across skincare, hair care and supplements. L'Oréal is adding prestige fragrance through Kering Beauté and a 50-year Gucci licence from July 2027.[1] Unilever is growing Liquid I.V., Olly and prestige brands such as Paula's Choice and Tatcha inside Beauty & Wellbeing.[3]
The changing shape of competitive advantage favours groups with clinical and wellness brands over mass-only portfolios. Beiersdorf is relying on Eucerin until Nivea recovers, and Coty is handing back the Gucci licence early.[7][6]
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| July 2026: L'Oréal signs a 50-year Gucci beauty licence. | Prestige fragrance demand. | Consolidation of luxury licences. | Fragrance sales from 2027. |
| July 2026: Unilever reports double-digit growth for Olly. | Ingestible wellness. | Supplements beside skincare. | Hair and sleep supplements. |
| August 2026: Beiersdorf launches an 18-month Nivea plan. | Weak mass skincare. | Lower entry prices. | Volume recovery from 2027. |
Source: Future Market Insights, Beauty and Wellness Market Report, 2026-2036.
Shoppers now judge a brand on proof of results and on online price. Groups with dermatologist programmes and strong marketplace teams will gain share from mass-only brands.
Who leads the beauty and wellness market?
Documented sales are largest at L'Oréal, which reported EUR 23.77 billion for January to June 2026.[1] Procter & Gamble and Unilever follow with broad skin, hair and wellness ranges.[5][3]
Which companies have documented positions?
Positions on record include Estée Lauder on tariff costs and marketplace expansion.[2] Shiseido documents a profit recovery with flat like-for-like sales.[8] Beiersdorf documents Derma growth and a Nivea turnaround plan.[7]
What should buyers evaluate before approving a supplier?
Claim evidence comes first, including SPF and dermatological testing, followed by ingredient compliance, promotional support, online pricing discipline and supply reliability. Pharmacy chains also ask for pharmacist training.
How is competition expected to change through 2036?
Groups will buy more clinical and wellness brands and trade luxury licences among themselves. Shoppers will reward proven results, so testing and claim support will decide more listings.
Representative Company Overview
| Company | Positioning | Recent development |
|---|---|---|
| L'Oréal | Largest beauty group with dermatological and luxury divisions | July 2026: Gucci beauty licence agreed from 2027. |
| Unilever | Consumer goods group with Beauty & Wellbeing and supplements | July 2026: 5.9% Beauty & Wellbeing growth reported. |
| Beiersdorf | Skincare group behind Nivea and Eucerin | August 2026: Nivea turnaround plan announced. |
Research Methodology
The companies included in the report represent current market structure and do not indicate a market-share ranking. Growth, tariff and recall facts were taken from company results, regulator actions and trade press dated May 2025 or later.
